Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-04-13 21:23 (1579 d 00:07 ago) – Posting: # 18680
Views: 1,892

Hi,

» Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT

I did a bunch of them a few years back but ours were NDAs (505b2s, ODTs vs reg tablets). Tablet on tongue, subject can't chew but can "suck" (you know, the small movement of your tongue like when you swallow something) on the tablet. After 10 or 30 seconds (don't remember details) check mouth. Once everything is disappear, then we give water...

Complete thread:

UA Flag
Activity
 Admin contact
22,289 posts in 4,666 threads, 1,585 registered users;
online 5 (0 registered, 5 guests [including 5 identified bots]).
Forum time: Tuesday 21:31 CEST (Europe/Vienna)

The existing scientific concepts cover always only
a very limited part of reality,
and the other part that has not yet
been understood is infinite.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5